118 results
8-K
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
an admission as to the materiality of any information in this Current Report on Form 8-K that is required to be disclosed solely by Regulation FD.
Item 9.01
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
STRATEGY & GOVERNANCE Conducted a revised global ESG materiality assessment Expanded ESG operating model to further align with company strategy
8-K
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
for the benefit of the parties thereto and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable
8-K
pc6go9nin4
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
tt9sf
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
bojoca7x
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
2rhuxa xt
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
afelxdh4r4rk8gyvot
25 Jan 24
Third party tender offer statement
8:13am
8-K
g7q6d0soqbex383sjd
8 Jan 24
Regulation FD Disclosure
10:29am
8-K
EX-99.1
pb9lvdw
8 Jan 24
Regulation FD Disclosure
10:29am
8-K
1xjehbgvpnu 9h
13 Nov 23
Other Events
4:19pm
8-K
2pu5 gvbfk3
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
46w379s7
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
v1nzqs
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
8-K
evgnk
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am
8-K
6e5rolhrstld2glj
27 Jul 22
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
7:44am
SC TO-T
EX-99
09mtt
17 Jun 22
Third party tender offer statement
4:42pm
SC TO-T
EX-99
f8qxxqn3s1 xmr
17 Jun 22
Third party tender offer statement
4:42pm